Mumbai, Oct. 6 -- Lupin has launched Formoflo-G(R) MDI, the world's first fixed dose triple combination metered-dose inhaler (MDI) for chronic obstructive pulmonary disease (COPD) in India, following approval from the Drug Controller General of India (DCGI). The launch marks a significant advancement in respiratory care, expanding treatment options for patients living with COPD.

Published by HT Digital Content Services with permission from Capital Market....